Speaking with LCGC, Alvarez explains why a single sharp peak can mask isomers that mass spec misses, and how a second separation exposes them.
Recap by typeshit. Full story at LCGC International.
A short post credits scientists with finding axolotl peptides that kill breast cancer cells. It names no study or team, so treat it as an early claim.
Pratt, a psychology professor who studies the circuits behind food motivation, walks through what neuroscience shows about these drugs.
Lilly's pill had major heart events in 4.2% of patients vs 5.0% on insulin glargine. The Clinical Trial Vanguard argues rivals now need to show benefit, not just safety.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
Its modelling suggests 5 million UK working-age adults could fall short on selenium, potassium and iron if GLP-1 use hits 15% and crop nutrients keep falling.
The update backs the drugs alongside lifestyle programs instead of after they fail, and advises against stopping them once they work, a shift for millions of veterans.
Loading…